Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03331250

Recruitment Status : Active, not recruiting

First Posted : November 6, 2017

Last Update Posted : March 20, 2023

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborator:

Eisai Inc.

Information provided by (Responsible Party):

Gregory Cote, Massachusetts General Hospital

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Actual Primary Completion Date :	July 21, 2022
Estimated Study Completion Date :	May 31, 2025

To Top